Experimental Melanoma Summary

Networked: 2655 relevant articles (117 outcomes, 271 trials/studies) for this Disease

Key Drugs and Agents for Experimental Melanoma

1. Antigens : 14 outcomes 14 studies in 144 results : IBA
   
2. DNA (Deoxyribonucleic Acid) : 8 outcomes 5 studies in 86 results : IBA
   
3. Interleukin-2 (IL2) : 5 outcomes 8 studies in 57 results : IBA
   
4. Monophenol Monooxygenase (Tyrosinase) : 4 outcomes 11 studies in 166 results : IBA
   
5. Cyclophosphamide (Cytoxan) : 4 outcomes 8 studies in 46 results : FDA 10 Generic
   
6. Doxorubicin (Adriamycin) : 4 outcomes 5 studies in 65 results : FDA 12 Generic
   
7. Interleukin-12 (IL 12) : 4 outcomes 5 studies in 30 results : IBA
   
8. Liposomes (Liposome) : 4 outcomes 3 studies in 39 results : IBA
   
9. Tumor Necrosis Factor-alpha (Tumor Necrosis Factor) : 3 outcomes 3 studies in 29 results : IBA
   
10. Interferon-gamma (Interferon, gamma) : 3 outcomes 1 study in 27 results : IBA
    

Diseases Related to Experimental Melanoma

1. Neoplasms (Cancer)
2. Melanoma (Melanoma, Malignant)
3. Neoplasm Metastasis (Metastasis)
4. Leukemia L1210
5. Sarcoma (Soft Tissue Sarcoma)

Key Therapies for Experimental Melanoma

1. Intravenous Injections : 6 outcomes 4 studies in 43 results
   
2. Immunotherapy : 4 outcomes 8 studies in 41 results
   
3. Heterologous Transplantation (Xenotransplantation) : 2 outcomes 5 studies in 55 results
   
4. Injections : 2 outcomes 1 study in 27 results
   
5. Oral Administration : 2 outcomes 1 study in 18 results